Our approach is platform-agnostic and is based on applying internal know-how acquired over years of experience.
With a strong technical background and sustained by a regulatory track record in process development, scale-up and GMP manufacturing of viral vectors for use in multitude of therapy indications, our expertise is extensive and includes Vaccines, Oncolytic Viruses (OV), Gene Therapy products, and other Immunotherapies.
Viral Vectors Portfolio
As a pioneer, we have been developing and producing viral vectors since the 1990s. We started with Pox Virus, MVA, Vaccinia and oncolytic viruses to support our clients’ clinical trials with the ultimate goal of fighting smallpox and several types of cancer.
